FDA Inspection 1334278 — Elizabeth A. Beierle Chen, MD
The FDA completed an inspection of Elizabeth A. Beierle Chen, MD on Aug 21, 2026 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Birmingham, AL (United States)
Additional Details
Clinical Investigator (CI)